highly significantp=0.002
Results The preoperative patient’s characteristics (risk factors) of both groups were comparable in both groups in all variables, except the following: The patients treated with InteguSeal ® showed a highly significant rate of lower ejection fraction (p=0.002), congestive heart failure (p=0.001) and acute myocardial infarction (p=0.008) compared with the control group.